Molecular Partners AG

Fr 2.60As of Sun 8 Nov 2026, 12:00 UTC
SWX:MOLNHealthcare
Country Switzerland
PE (Fwd) •••
TSR 10Y CAGR (19.89%)
Div yield —
ROE (69.85%)
Biotechnology
Beta (5Y) 0.60
PE TTM —
TSR TTM (10.34%)
Mkt cap Fr 99.67M
ROIC (43.00%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
Fr 3.03
16.70%
10.30%
Hold 6|0|3|1|5
4Q25
1Q26
2Q26
3Q26
Earnings per shareFr
0.03
0.03
0.03
0.03
9.28%
17.72%
20.02%
17.47%
RevenueFr M
7.889
7.684
7.776
8.064
6.64%
1.38%
2.84%
3.53%
Peers (US$122.2M)
Cap (US$)
PE
221.7M
—
161.1M
—
59.55M
—
Capital
TTM
5Y
10Y
Leveragex
0.358
0.331
0.270
EBIT/Intx
0.523
0.070
0.057
Own earn%
229.04
(81.00)
(62.13)
Sh yield%
34.01
39.84
44.33
Owners
Insiders/Inst%
5.26
69.63
Short interest%
2.46
SBC / revenue%
2.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
24–30
$1 testx
—
Incr. ROIC%
3